Skip to search formSkip to main contentSkip to account menu

naratriptan

Known as: naratriptan [Chemical/Ingredient], N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide, N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide 
National Institutes of Health

Related topics

Related topics

17 relations

Narrower (3)

AmergeColatanNaramig
Angina Pectoris, VariantCerebral Arterial Vasoconstriction [PE]Cerebrovascular accidentDrug Allergy

Broader (4)

PiperidinesSerotonin 5-HT1 Receptor AgonistsTryptaminesVasoconstrictor Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: A Fos protein study
2005
2005
The Combination of Naratriptan and Prochlorperazine in Migraine Treatment
Understanding of the pathophysiological mechanisms of migraine has led to treatment with serotonin agonists, most notably the… 
2005
2005
Uncertainty Analysis in Pharmacokinetics and Pharmacodynamics: Application to Naratriptan
PurposeThe aim of the study was to predict pain relief of migraine in patients following naratriptan oral (tablet) administration… 
2004
2004
Cost Considerations of Acute Migraine Treatment
Objective.—To provide medication price data and cost‐reducing strategies for the acute treatment of migraine. 
2003
2003
S(+)-flurbiprofen but not 5-HT1 agonists suppress basal and stimulated CGRP and PGE2 release from isolated rat dura mater
2001
2001
Modeling and Simulation for Clinical Trial Design Involving a Categorical Response: A Phase II Case Study with Naratriptan
AbstractPurpose. The overall aim of the present study was to investigate retrospectively the feasibility and utility of model… 
Review
2001
Review
2001
Current options for the prevention and treatment of migraine.
2001
2001
Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
1999
1999
Naratriptan is effective and well tolerated in the acute treatment of migraine.
To the Editor: The publication on the efficacy of the new second-generation 5-hydroxytryptamine (5HT)1B/1D agonist naratriptan… 
Review
1999
Review
1999
Symptomatic pharmacotherapy of migraine.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)